Literature DB >> 5818724

Therapeutic nonequivalence of oxytetracycline capsules.

G W Brice, H F Hammer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5818724

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Bioavailability of commercial tetracycline products.

Authors:  D B Barnett; R N Smith; N D Greenwood; C Hetherington
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

Review 2.  Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.

Authors:  O I Corrigan; R F Timoney
Journal:  Ir J Med Sci       Date:  1974-07       Impact factor: 1.568

3.  Rapid, precise, turbidometric assay for low levels of ampicillin in serum after single-dose oral administration.

Authors:  P L Whyatt; R E Dann; G W Slywka; M C Meyer
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

4.  Bioinequivalence and drug toxicity. How great is the problem and what can be done?

Authors:  C H Gleiter; U Gundert-Remy
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

5.  Scientific principles in design of drug dosage formulations.

Authors:  S S Davis
Journal:  Br Med J       Date:  1972-01-08

6.  Biological availability and in vitro dissolution of oxytetracycline dihydrate tablets.

Authors:  H E Barber; T N Calvey; K Muir; A Hart
Journal:  Br J Clin Pharmacol       Date:  1974-10       Impact factor: 4.335

7.  Bioavailability and dissolution of different formulations of oxytetracycline preparations.

Authors:  A Hart; H E Barber; T N Calvey
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

8.  Comparative bioavailability of tetracycline and lymecycline.

Authors:  G Sjölin-Forsberg; J Hermansson
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

9.  Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects.

Authors:  P G Welling; P A Koch; C C Lau; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

Review 10.  Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs.

Authors:  Roberta Censi; Piera Di Martino
Journal:  Molecules       Date:  2015-10-15       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.